Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-10-02

Clinical Trial Update: N-3 PUFA and Rheumatoid Arthritis in Korea [NA]

View source ↗

Summary

A completed clinical trial in Korea evaluating N-3 PUFA (omega-3 polyunsaturated fatty acids) for rheumatoid arthritis has posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • N-3 PUFA (omega-3 polyunsaturated fatty acids)

Snippet

Sponsor: Hanyang University | Conditions: Rheumatoid Arthritis | NA | Status: COMPLETED | Results posted: 2012-10-02